Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Accessory gene regulator protein A (AgrA) is a DNA-binding response regulator that functions in the two-component Agr quorum-sensing system in Staphylococcus aureus and some other staphylococci[1][2][3][6][8][9]. It has an N-terminal CheY-like receiver domain and a C-terminal LytTR DNA-binding domain[1][3][5]. Upon receiving a phosphate from the sensor kinase AgrC in response to autoinducing peptide (AIP) signaling, phosphorylated AgrA dimerizes and binds to specific promoter regions (notably P2 and P3), activating transcription of genes, including those for toxins and other virulence factors[1][2][5]. AgrA is a key regulator of virulence, exoprotein synthesis, and stress responses in S. aureus, making it a validated but challenging target for antimicrobial drug development[3][4]. Small molecule inhibitors that target AgrA's DNA-binding activity have been reported in early-stage research[3]. AgrA's critical role in regulating pathogenicity links it to infection and virulence as disease roles, particularly in staphylococcal infections.
Inhibition of DNA binding to prevent activation of quorum-sensing-regulated virulence genes [3]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Accessory gene regulator protein A (AgrA).